Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome

Ridder, Dirk AndreasUrbansky, Lana LouisaWitzel, Hagen RolandSchindeldecker, MarioWeinmann, ArndtBerndt, KristinaGerber, Tiemo SvenKöhler, Bruno ChristianNichetti, FedericoLudt, AnnekathrinGehrke, NadineSchattenberg, Jörn MarkusHeinrich, StefanRoth, WilfriedStraub, Beate Katharina2023-01-132023-01-132022https://openscience.ub.uni-mainz.de/handle/20.500.12030/7265engCC-BY-4.0https://creativecommons.org/licenses/by/4.0/610 Medizin610 Medical sciencesTransforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcomeZeitschriftenaufsatz